DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,200 filers reported holding DANAHER CORPORATION in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,313,506 | +3.9% | 102,029 | +0.5% | 2.20% | +9.2% |
| Q2 2023 | $24,367,918 | -2.9% | 101,533 | +1.9% | 2.02% | -6.5% |
| Q1 2023 | $25,106,129 | -3.2% | 99,612 | +2.0% | 2.16% | -6.3% |
| Q4 2022 | $25,927,932 | +4.7% | 97,686 | +1.9% | 2.30% | -1.1% |
| Q3 2022 | $24,755,000 | +1.7% | 95,843 | -0.2% | 2.32% | +10.4% |
| Q2 2022 | $24,353,000 | -13.6% | 96,059 | -0.1% | 2.11% | -15.0% |
| Q1 2022 | $28,194,000 | -7.2% | 96,117 | +4.1% | 2.48% | +10.2% |
| Q4 2021 | $30,375,000 | +8.8% | 92,321 | +0.7% | 2.25% | -5.9% |
| Q3 2021 | $27,907,000 | -2.0% | 91,667 | -13.6% | 2.39% | -2.0% |
| Q2 2021 | $28,485,000 | +21.8% | 106,145 | +2.2% | 2.44% | +12.8% |
| Q1 2021 | $23,384,000 | +21.5% | 103,892 | +19.9% | 2.16% | -6.2% |
| Q4 2020 | $19,242,000 | -10.8% | 86,619 | -13.5% | 2.31% | -5.1% |
| Q3 2020 | $21,572,000 | +22.4% | 100,182 | +0.6% | 2.43% | +13.5% |
| Q2 2020 | $17,618,000 | +33.0% | 99,633 | +4.1% | 2.14% | +8.3% |
| Q1 2020 | $13,246,000 | -8.0% | 95,704 | +2.0% | 1.98% | +17.6% |
| Q4 2019 | $14,397,000 | +6.7% | 93,804 | +0.4% | 1.68% | -2.1% |
| Q3 2019 | $13,498,000 | +1.7% | 93,454 | +0.6% | 1.72% | -18.2% |
| Q2 2019 | $13,278,000 | +11.8% | 92,903 | +3.3% | 2.10% | +8.9% |
| Q1 2019 | $11,873,000 | +26.3% | 89,932 | -1.4% | 1.93% | +15.9% |
| Q4 2018 | $9,404,000 | -5.9% | 91,190 | -0.8% | 1.66% | +6.9% |
| Q3 2018 | $9,990,000 | +10.6% | 91,943 | +0.5% | 1.55% | +7.5% |
| Q2 2018 | $9,030,000 | +2.8% | 91,505 | +2.0% | 1.44% | -5.1% |
| Q1 2018 | $8,786,000 | +4.5% | 89,731 | -0.9% | 1.52% | +8.1% |
| Q4 2017 | $8,405,000 | +7.7% | 90,548 | -0.4% | 1.41% | +3.6% |
| Q3 2017 | $7,801,000 | +2.3% | 90,937 | +0.6% | 1.36% | -0.1% |
| Q2 2017 | $7,629,000 | -1.5% | 90,401 | -0.1% | 1.36% | -5.3% |
| Q1 2017 | $7,742,000 | +10.7% | 90,516 | +0.7% | 1.44% | +3.9% |
| Q4 2016 | $6,994,000 | -0.8% | 89,855 | -0.1% | 1.38% | -3.2% |
| Q3 2016 | $7,050,000 | -21.9% | 89,930 | +0.6% | 1.43% | -22.3% |
| Q2 2016 | $9,027,000 | +11.4% | 89,372 | +4.7% | 1.84% | +3.8% |
| Q1 2016 | $8,100,000 | +1.5% | 85,385 | -0.6% | 1.77% | +0.5% |
| Q4 2015 | $7,980,000 | +19.2% | 85,919 | +9.4% | 1.76% | +11.8% |
| Q3 2015 | $6,692,000 | +10.5% | 78,530 | +11.0% | 1.58% | +19.1% |
| Q2 2015 | $6,054,000 | – | 70,731 | – | 1.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |